Stancheva S, Alova L, Georgiev V
Radioizotope Laboratory, Institute of Physiology, Bulgarian Academy of Sciences, Sofia, Bulgaria.
Acta Physiol Pharmacol Bulg. 2000;25(2):51-6.
The effects of i.c.v. administered peptide and nonpeptide ANG II-receptor ligands (losartan, EXP 3174, saralasin and sarmesin) on monoamine oxidase A (MAO-A) and MAO-B activities in the frontal cortex, striatum, hypothalamus and hippocampus of water-repleted rats were investigated. Alterations in MAO-A and MAO-B activities were found in different rat brain regions after ANG II which depended on the isoenzyme type and brain structure. MAO-A activity significantly increased in the frontal cortex and hypothalamus, brain regions containing AT1 receptors, mainly. MAO-A and MAO-B activities were affected differently by all studied ANG II-receptor ligands, which in most cases antagonized the effect of ANG II (losartan, an AT1-nonpeptide receptor antagonist being the most effective). There was no clearcut relationship between the inhibition of ANG II-induced water intake and the changes of MAO-A and MAO-B activities under the effect of the ANG II-receptor antagonists studied.
研究了脑室内注射肽类和非肽类血管紧张素II受体配体(氯沙坦、EXP 3174、沙拉新和沙美辛)对饮水充足大鼠额叶皮质、纹状体、下丘脑和海马中单胺氧化酶A(MAO-A)和单胺氧化酶B(MAO-B)活性的影响。血管紧张素II后,不同大鼠脑区的MAO-A和MAO-B活性发生改变,这取决于同工酶类型和脑结构。MAO-A活性在额叶皮质和下丘脑显著增加,这些脑区主要含有AT1受体。所有研究的血管紧张素II受体配体对MAO-A和MAO-B活性的影响不同,在大多数情况下,它们拮抗血管紧张素II的作用(氯沙坦,一种AT1非肽受体拮抗剂最为有效)。在所研究的血管紧张素II受体拮抗剂作用下,血管紧张素II诱导的饮水抑制与MAO-A和MAO-B活性变化之间没有明确的关系。